Silencing of miR-183 in RMS cells revealed deregulation of a miRNA network composed of miR-183-EGR1-PTEN miR-183-EGR1-PTEN miR-183-EGR1-PTEN miR-183-EGR1-PTEN
Characterizing the deregulation of signaling networks is a crucial component of understanding a variety of diseases, including diabetes [ 1, 2] developmental disorders [ 3], and cancer [ 3- 5].
Deregulation of this network might result in synergistic effects on hematopoietic differentiation, which promotes transformation of GATA1s-mutated fetal hematopoietic progenitor cells.
Likewise, upregulation of DPAGT1 expression either by activating mutations or by increased availability of UDP-GlcNAc from glycolysis may initiate the deregulation of the network.
Although the present study included tagging SNPs in most currently known miRNA biogenesis pathway genes, future studies should investigate the comprehensive list of genetic variants in miRNA genes and target binding site in 3'-untranslated 3'-untranslatedstand how theiregiongulatoon of miRNA network caunderstandtially by thowgenetheirariants is implicatederegulationcancer profnosis.
Collectively, these data suggest that both epigenetic and copy number disruptions play a cumulative role in deregulation of gene networks in OS cell lines.
Since ETS1 promotes the survival of T cells (Muthusamy et al, 1995) and is overexpressed in T-ALL (Sacchi et al, 1988), deregulation of its transcriptional network by TAL1 might also have a major role in TAL1-mediated leukaemogenesis.
However, the mechanism through which miRNA expression is deregulated in cancer and CLL is poorly characterized, and it is not clear whether it is a primary or secondary event caused by deregulation of transcription networks (5), chromatin structure (48, 49) or other mechanisms.
Thanks to more competition, deregulation of the telephone network's "last mile"—ie, between the local exchange and the subscriber was supposed to usher in a plethora of cheap broadband services for those who could not afford the high-speed leased lines used by large companies.
However, advanced disease patients develop multiple immune defects, including hypogammaglobulinemia, deregulation of the cytokine network, or impairment of T and NK cells function [ 6].
